338 related articles for article (PubMed ID: 33352882)
1. Modulating the Tumour Microenvironment by Intratumoural Injection of Pattern Recognition Receptor Agonists.
Burn OK; Prasit KK; Hermans IF
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33352882
[TBL] [Abstract][Full Text] [Related]
2. Intratumoural administration of an NKT cell agonist with CpG promotes NKT cell infiltration associated with an enhanced antitumour response and abscopal effect.
Prasit KK; Ferrer-Font L; Burn OK; Anderson RJ; Compton BJ; Schmidt AJ; Mayer JU; Chen CJ; Dasyam N; Ritchie DS; Godfrey DI; Mattarollo SR; Dundar PR; Painter GF; Hermans IF
Oncoimmunology; 2022; 11(1):2081009. PubMed ID: 35712122
[TBL] [Abstract][Full Text] [Related]
3. The Combination Immunotherapy of TLR9 Agonist and OX40 Agonist via Intratumoural Injection for Hepatocellular Carcinoma.
Zhou Z; Lin L; An Y; Zhan M; Chen Y; Cai M; Zhu X; Lu L; Zhu K
J Hepatocell Carcinoma; 2021; 8():529-543. PubMed ID: 34136421
[TBL] [Abstract][Full Text] [Related]
4. Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants.
Ong GH; Lian BSX; Kawasaki T; Kawai T
Front Cell Infect Microbiol; 2021; 11():745016. PubMed ID: 34692565
[TBL] [Abstract][Full Text] [Related]
5. Toll-Like Receptors Signaling in the Tumor Microenvironment.
McCall KD; Muccioli M; Benencia F
Adv Exp Med Biol; 2020; 1223():81-97. PubMed ID: 32030686
[TBL] [Abstract][Full Text] [Related]
6. The Innate Immune Signalling Pathways: Turning RIG-I Sensor Activation Against Cancer.
Iurescia S; Fioretti D; Rinaldi M
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33121210
[TBL] [Abstract][Full Text] [Related]
7. Intratumoural administration and tumour tissue targeting of cancer immunotherapies.
Melero I; Castanon E; Alvarez M; Champiat S; Marabelle A
Nat Rev Clin Oncol; 2021 Sep; 18(9):558-576. PubMed ID: 34006998
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 9 agonists and combination therapies: strategies to modulate the tumour immune microenvironment for systemic anti-tumour immunity.
Dongye Z; Li J; Wu Y
Br J Cancer; 2022 Nov; 127(9):1584-1594. PubMed ID: 35902641
[TBL] [Abstract][Full Text] [Related]
9. Innate and Adaptive Responses of Intratumoral Immunotherapy with Endosomal Toll-Like Receptor Agonists.
Andón FT; Leon S; Ummarino A; Redin E; Allavena P; Serrano D; Anfray C; Calvo A
Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35884895
[TBL] [Abstract][Full Text] [Related]
10. Context-dependent functions of pattern recognition receptors in cancer.
Man SM; Jenkins BJ
Nat Rev Cancer; 2022 Jul; 22(7):397-413. PubMed ID: 35355007
[TBL] [Abstract][Full Text] [Related]
11. Intratumoural immunotherapies in oncology.
Xu W; Atkinson VG; Menzies AM
Eur J Cancer; 2020 Mar; 127():1-11. PubMed ID: 31962197
[TBL] [Abstract][Full Text] [Related]
12. Engaging Pattern Recognition Receptors in Solid Tumors to Generate Systemic Antitumor Immunity.
Brown M
Cancer Treat Res; 2022; 183():91-129. PubMed ID: 35551657
[TBL] [Abstract][Full Text] [Related]
13. Current strategies for intratumoural immunotherapy - Beyond immune checkpoint inhibition.
Yuan J; Khilnani A; Brody J; Andtbacka RHI; Hu-Lieskovan S; Luke JJ; Diab A; Marabelle A; Snyder A; Cao ZA; Hodi FS
Eur J Cancer; 2021 Nov; 157():493-510. PubMed ID: 34561127
[TBL] [Abstract][Full Text] [Related]
14. Systemic immune responses to irradiated tumours via the transport of antigens to the tumour periphery by injected flagellate bacteria.
Wang W; Xu H; Ye Q; Tao F; Wheeldon I; Yuan A; Hu Y; Wu J
Nat Biomed Eng; 2022 Jan; 6(1):44-53. PubMed ID: 35058589
[TBL] [Abstract][Full Text] [Related]
15. Intratumoural immunotherapy: activation of nucleic acid sensing pattern recognition receptors.
Agrawal S; Kandimalla ER
Immunooncol Technol; 2019 Oct; 3():15-23. PubMed ID: 35757301
[TBL] [Abstract][Full Text] [Related]
16. Ponatinib delays the growth of solid tumours by remodelling immunosuppressive tumour microenvironment through the inhibition of induced PD-L1 expression.
Barnwal A; Tamang R; Sanjeev Das ; Bhattacharyya J
Br J Cancer; 2023 Oct; 129(6):1007-1021. PubMed ID: 37400678
[TBL] [Abstract][Full Text] [Related]
17. Powerful Complex Immunoadjuvant Based on Synergistic Effect of Combined TLR4 and NOD2 Activation Significantly Enhances Magnitude of Humoral and Cellular Adaptive Immune Responses.
Tukhvatulin AI; Dzharullaeva AS; Tukhvatulina NM; Shcheblyakov DV; Shmarov MM; Dolzhikova IV; Stanhope-Baker P; Naroditsky BS; Gudkov AV; Logunov DY; Gintsburg AL
PLoS One; 2016; 11(5):e0155650. PubMed ID: 27187797
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of CD47 Is a Host Checkpoint Response to Pathogen Recognition.
Tal MC; Torrez Dulgeroff LB; Myers L; Cham LB; Mayer-Barber KD; Bohrer AC; Castro E; Yiu YY; Lopez Angel C; Pham E; Carmody AB; Messer RJ; Gars E; Kortmann J; Markovic M; Hasenkrug M; Peterson KE; Winkler CW; Woods TA; Hansen P; Galloway S; Wagh D; Fram BJ; Nguyen T; Corey D; Kalluru RS; Banaei N; Rajadas J; Monack DM; Ahmed A; Sahoo D; Davis MM; Glenn JS; Adomati T; Lang KS; Weissman IL; Hasenkrug KJ
mBio; 2020 Jun; 11(3):. PubMed ID: 32576678
[TBL] [Abstract][Full Text] [Related]
19. Pattern-recognition receptors in endometriosis: A narrative review.
Guo B; Chen JH; Zhang JH; Fang Y; Liu XJ; Zhang J; Zhu HQ; Zhan L
Front Immunol; 2023; 14():1161606. PubMed ID: 37033937
[TBL] [Abstract][Full Text] [Related]
20. 5-Aza-2'-deoxycytidine potentiates antitumour immune response induced by photodynamic therapy.
Wachowska M; Gabrysiak M; Muchowicz A; Bednarek W; Barankiewicz J; Rygiel T; Boon L; Mroz P; Hamblin MR; Golab J
Eur J Cancer; 2014 May; 50(7):1370-81. PubMed ID: 24559534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
